POST FINASTERIDE SYNDROME & More|| Leo Answers Your Podcast Questions || Episode 2 || Part 2

Key Wellness / Self-Care / Productivity Strategies Mentioned

Hormone & Recovery Guidance (Especially Post–Finasteride Concerns)

PCT core principle: control estradiol

• Aim to control estradiol to help the brain restart normal steroid signaling.
• Target range suggested:
  • Estradiol (E2): ~15–25 pg/mL
  • Ideally closer to ~15

Adjunct idea: opioid receptor blockade

• Consider naloxone 50 mg every other day (speaker’s experience).

Conceptual HCG approach

• Some use HCG temporarily to “wake up” testicular function.
• The idea is to do this while blocking estradiol, then discontinue HCG so the brain can normalize feedback.

Warning framing

• “Not medical advice” is emphasized.
• Concern noted: long-term HCG at high doses may increase risk related to testicular cancer (speaker’s personal concern).

Post-finasteride syndrome (PFS): legitimacy & mechanism (as described)

• Suggested mechanisms:
  • Epigenetic changes
  • Longer-lasting shifts in gene expression
• Brain effects described:
  • Reduced GABAergic inhibition (via allopregnanolone/GABA-A pathway ideas)
  • More excitatory activity
  • Oxidative stress
  • Possible brain fog and sensory sensitivity
• Sexual function effects (as described):
  • Reduced local androgen signaling → reduced blood flow
  • Possible tissue cell death (rodent-based explanation)

Symptom-reduction strategies discussed for PFS

• Wellbutrin (bupropion)
  • Reported by some to improve symptoms
  • Example dosing pattern mentioned: several days/week in the morning (possibly split morning/noon)
• Sodium valproate
  • Very slow titration
  • Example: 250 mg extended release, once or twice daily
  • Increase only if there are no GI side effects

---

Dangerous Drug Cautions / Risk-Management Messaging

DNP (2,4-dinitrophenol)

• Described as a mitochondrial uncoupler
• Speaker reports:
  • Personal experience with muscle “losing look”
  • Water retention/subcutaneous water changes
• Strong warning:
  • “People will die” if misused
  • Not worth it for simple fat loss

Combining DNP with GLP-1 agonists

• Speaker says there’s “no reason” you couldn’t combine them
• However, uncertainty and risk are acknowledged
• Careful dosing might be safer, but lethality risk remains emphasized

---

Training / Body Composition Principles (High-Level)

Androgen/anabolic concept clarification

• Pushback on using “anabolic vs androgenic” too rigidly.
• Most testosterone derivatives are androgens with varying muscle-trophic effects.
• Speaker notes they don’t personally know much about hypertrophy training specifics.

Fasting and muscle loss (metabolic view)

• Claims short fasts don’t cause much muscle loss.
• But if fasting is frequent (example: 5 days monthly), there may be periods of low IGF-1, which could affect long-term muscle building.

When to fast (Longo/Walter Longo reference)

• Adults: fasting “dose” based on body/impact, examples given:
  • 5 days monthly
  • 5 days quarterly
  • 5 days every 6 months
  • 5 days once/year
• Teens: cautioned against fasting during adolescence due to possible impacts on:
  • Growth/height
  • IGF-1
• Speaker prioritizes reaching maximal height.

---

Supplements / Health Ideas

Kidney health & PKD question

• Speaker doesn’t claim PKD expertise, but offers possible rationale:
  • More carbs → more glycogen/fluid and increased kidney workload stress
  • Sugar → oxidative stress / potential cytotoxicity
• Suggests deeper research via Google Scholar (scholar.google.com).

Astringent kidney supplement: astragalus

• Mostly framed as anecdotal
• Notes need for better academic research

T4 dosing (for someone using HCG)

• Suggest taking T4 in the morning
• Target: TSH ~0.5–1.0
• Example framework:
  • Start 50 mcg levothyroxine
  • Adjust based on bloodwork
  • Dose may increase toward 100–200 mcg depending on TSH
• Reminder: not medical advice.

Artificial sweeteners vs sugar

• Doesn’t demonize artificial sweeteners as much as sugar.
• Says sugar/carbs/fructose are more damaging than artificial sweeteners.
• Mentions stevia positively.

E-readers vs paper (learning/productivity angle)

• Prefers physical engagement:
  • underline, annotate, hold the paper
  • improves memory/engagement
• Acknowledges e-readers can help, but may be limited by “less physical” experience.

Modafinil discussion (sleep/productivity)

• Claims modafinil is less “dopaminergic” than stimulants like methylphenidate/amphetamine
• Suggests it mainly increases noradrenaline for wakefulness
• Claim: modafinil harms sleep regardless of what you do
• Calls it a “poor man’s” alternative

---

Injection-Site Advice (Practical Harm Reduction)

Quads vs other sites

• Speaker reports no personal issues injecting quads.
• Later preference: small-needle approaches.

Preferred method described: chest/pec area with backloaded insulin syringe

• Reported as easier with insulin syringes
• May reduce scar tissue compared to big needles
• Recommends learning backloading insulin syringes via YouTube
  • Example mentioned: Tony Huge

---

Medication / Mental-Health Framing (Cautious, Selective Use)

SSRI use (neuro health / dementia risk)

• Speaker does not recommend SSRIs for everyone.
• Framed as more relevant for people aiming to reduce dementia risk (and possibly anxiety/depression).

SSRI vs nootropics (alpha-GPC/cholinergic)

• Speaker claims SSRIs are not primarily anti-cholinergic.
• Emphasizes anti-dopaminergic/serotonin effects
• Discusses how those effects can blunt stimulant activity.

---

Safety in Medical Tourism

Turkey for hair transplants / gyno surgery

• Strongly advised against seeking these procedures abroad for cost reasons.
• Belief: outcomes depend heavily on doctor skill
• Warning: failures/inferior patterns are a risk.
• Speaker says they wouldn’t do gynecology surgery outside the US.
• If doing in the US, only with a small number of vetted doctors.

---

Methods / Rules Explicitly Presented

• Estradiol control for PCT concepts: keep E2 ~15–25 pg/mL, ideally nearer ~15.
• Naloxone adjunct idea: 50 mg every other day for a few weeks, then retest levels.
• HCG strategy (conceptual): temporary HCG to restart testicular function while controlling estradiol, then stop after the “wake-up” phase.
• T4 dosing (example framework):
  • Start 50 mcg in the morning
  • Test TSH, adjust until TSH ~0.5–1.0
• Valproate titration framework (speaker’s example):
  • 250 mg ER (example: twice daily / every ~12 hours)
  • Increase only if there are no GI side effects
• Fasting frequency examples (Longo reference):
  • Adults: fasting 5 days/month, 5 days/quarter, 5 days/6 months, or once/year
  • Teens: avoid fasting until after maximal height if possible (speaker’s view)

---

Presenters / Sources Mentioned

Presenter

• Leo (host of “Leo Answers Your Podcast Questions”; referred to as “Leo” throughout)

Referenced individuals / channels

• Derek (for hair-loss prevention compound avoidance)
• Tony Huge (YouTube example for backloading insulin syringes)
• Boston (frequent reference, including DNP/brain/mitochondrial topics)
• Ariella Palumbo / “Boston’s wife” (mentioned as returning for PEDS discussion)
• Victor Black (mentioned in hair-loss safety context)

Referenced research / authors

• Walter Longo (fasting guidance, cited via a “world’s best resource” description)
• boston also mentioned as having experience (not necessarily academic)

Referenced organizations/places/tools

• Google Scholar (recommended for research)
• Scholar.google.com (as written)

Referenced substances (topics, not endorsements)

• Finasteride, clomiphene (Clomid), aromatase inhibitors
• Opioids/naloxone, HCG
• DNP, GLP-1 agonists
• T4/T3
• Metformin
• Astragalus
• Valproate
• Wellbutrin (bupropion)
• Minoxidil
• ru/dutasteride/finasteride (scalp)
• Modafinil
• SSRIs (e.g., fluvoxamine, amitriptyline)
• Donepezil, memantine
• Dextromphetamine
• Ketogenic diets/fasting
• Empagliflozin
• Nitric/nitrosamine-related phytochemicals
• Nitrates/poppers